TY  - GEN
AU  - Woo,Jong Shin
AU  - Kim,Weon
AU  - Ha,Sang Jin
AU  - Kim,Jin Bae
AU  - Kim,Soo-Joong
AU  - Kim,Woo-Shik
AU  - Seon,Hyun Ju
AU  - Kim,Kwon Sam
TI  - Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study
SN  - 1524-4636
PY  - 2013///1112
KW  - Aged
KW  - Biomarkers
KW  - blood
KW  - Cardiotonic Agents
KW  - administration & dosage
KW  - Chi-Square Distribution
KW  - Creatine Kinase, MB Form
KW  - Drug Administration Schedule
KW  - Echocardiography, Doppler
KW  - Exenatide
KW  - Female
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Injections, Subcutaneous
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Myocardial Contraction
KW  - drug effects
KW  - Myocardial Infarction
KW  - Myocardium
KW  - enzymology
KW  - Peptides
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Predictive Value of Tests
KW  - Proportional Hazards Models
KW  - Prospective Studies
KW  - Republic of Korea
KW  - Stroke Volume
KW  - Time Factors
KW  - Treatment Outcome
KW  - Troponin I
KW  - Venoms
KW  - Ventricular Function, Left
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/ATVBAHA.113.301586
ER  -